Role of IGFBP-4 in Preventing Colon Cancer
Author Information
Author(s): Durai Rajaraman, Yang Shi, Seifalian Alexander, Goldspink Geoffrey, Winslet Marc C
Primary Institution: University College London
Hypothesis
Does insulin-like growth factor binding protein-4 (IGFBP-4) prevent the development of colon cancer?
Conclusion
IGFBP-4 gene therapy did not prevent colon cancer initiation but increased apoptosis and decreased tumor cell division.
Supporting Evidence
- IGFBP-4 gene therapy did not prevent tumor establishment.
- Tumor apoptosis increased in the IGFBP-4 treated group.
- Bax protein expression was higher in tumors treated with IGFBP-4.
- Tumor volume and weight were similar across treatment groups.
Takeaway
The study tested if a protein could stop colon cancer from starting, but it didn't work; however, it did help more cancer cells die.
Methodology
Nude mice were injected with colon cancer cells and treated with IGFBP-4 gene therapy, then assessed for tumor characteristics after four weeks.
Limitations
The study did not assess long-term outcomes or survival rates of the mice.
Participant Demographics
MF1 nu/nu male athymic mice, aged 4-6 weeks.
Statistical Information
P-Value
0.0002
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website